Domain Associates and Catalys Pacific Launch Exalys Therapeutics to Develop Portfolio of Next-Generation EP4 Antagonists

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/2ZC0H8K
via IFTTT